Solid forms of a Raf kinase inhibitor

Details for Australian Patent Application No. 2008251764 (hide)

Owner Novartis AG

Inventors Lin, Kangwen L.; Hashash, Ahmad; Okhamafe, Augustus O.

Agent Davies Collison Cave

Pub. Number AU-B-2008251764

PCT Pub. Number WO2008/140850

Priority 60/904,455 02.03.07 US

Filing date 28 February 2008

Wipo publication date 20 November 2008

Acceptance publication date 13 September 2012

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/4439

A61P 35/00 Antineoplastic agents

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/140850 Priority application(s): WO2008/140850

13 September 2012 Application Accepted

  Published as AU-B-2008251764

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008251773-Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity

2008251756-Methods and compositions for heavy metal detoxification